Table 4.
Intervention (n=484) |
Control (n=488) |
|
Serious adverse events (≥1)*, n (%) | 25 (5.2%) | 25 (5.1%) |
Adverse events (≥1), n (%) | ||
Throat/mouth irritation (extreme) | 10 (3.2%) | 8 (2.7%) |
n=310 | n=293 | |
Dry cough (extreme) | 13 (4.2%) | 12 (4.1%) |
n=310 | n=292 |
*All serious adverse events resulting in hospitalisation over the study period.